4.7 Article

Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Serum leptin: A marker of prostate cancer irrespective of obesity

S. K. Singh et al.

CANCER BIOMARKERS (2010)

Article Surgery

Leptin Levels in Thyroid Cancer

Melih Akinci et al.

ASIAN JOURNAL OF SURGERY (2009)

Article Oncology

Circulating levels of leptin, adiposity and breast cancer risk

M-H Wu et al.

BRITISH JOURNAL OF CANCER (2009)

Article Medicine, General & Internal

Increasing incidence of thyroid cancer in the United States, 1973-2002

L Davies et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Otorhinolaryngology

Management and outcome, of recurrent well-differentiated thyroid carcinoma

CE Palme et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)

Article Endocrinology & Metabolism

Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes

J Modi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)

Article Oncology

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

AW Hsing et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)

Review Oncology

Death receptor ligands, in particular TRAIL, to overcome drug resistance

S de Jong et al.

CANCER AND METASTASIS REVIEWS (2001)

Review Multidisciplinary Sciences

CD95's deadly mission in the immune system

PH Krammer

NATURE (2000)

Article Biochemistry & Molecular Biology

TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention

M Ahmad et al.

ONCOGENE (2000)